May Tun Saung

1.2k total citations
15 papers, 927 citations indexed

About

May Tun Saung is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, May Tun Saung has authored 15 papers receiving a total of 927 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 7 papers in Immunology and 3 papers in Molecular Biology. Recurrent topics in May Tun Saung's work include Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Immunotherapy and Immune Responses (3 papers). May Tun Saung is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Immunotherapy and Immune Responses (3 papers). May Tun Saung collaborates with scholars based in United States, Japan and India. May Tun Saung's co-authors include Lei Zheng, Arsen Osipov, Adrian Murphy, Gregory P. Howard, Xiyu Ke, Hai‐Quan Mao, Zahi A. Fayad, Alex B. Blair, Stephen Muth and Bei Cheng and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Drug Delivery Reviews and Clinical Cancer Research.

In The Last Decade

May Tun Saung

15 papers receiving 919 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
May Tun Saung United States 12 392 339 268 264 111 15 927
James W. Opzoomer United Kingdom 8 370 0.9× 275 0.8× 329 1.2× 171 0.6× 66 0.6× 11 828
Myrofora Panagi Cyprus 15 312 0.8× 223 0.7× 297 1.1× 297 1.1× 105 0.9× 24 883
Crismita Dmello United States 12 305 0.8× 291 0.9× 363 1.4× 247 0.9× 88 0.8× 32 974
Xiaoli Wei China 13 202 0.5× 217 0.6× 332 1.2× 312 1.2× 100 0.9× 30 776
Ashvin R. Jaiswal United States 9 387 1.0× 482 1.4× 215 0.8× 161 0.6× 107 1.0× 14 914
Matthew Lin United States 6 387 1.0× 524 1.5× 340 1.3× 288 1.1× 61 0.5× 10 899
Yuan‐Tong Liu China 14 384 1.0× 365 1.1× 319 1.2× 193 0.7× 146 1.3× 18 894
Chayanon Ngambenjawong United States 10 245 0.6× 472 1.4× 498 1.9× 244 0.9× 104 0.9× 15 1.0k
Christina Hartl United States 7 440 1.1× 460 1.4× 372 1.4× 344 1.3× 77 0.7× 11 1.0k
Lenka Kašíková Czechia 10 564 1.4× 716 2.1× 337 1.3× 273 1.0× 197 1.8× 12 1.3k

Countries citing papers authored by May Tun Saung

Since Specialization
Citations

This map shows the geographic impact of May Tun Saung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by May Tun Saung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites May Tun Saung more than expected).

Fields of papers citing papers by May Tun Saung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by May Tun Saung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by May Tun Saung. The network helps show where May Tun Saung may publish in the future.

Co-authorship network of co-authors of May Tun Saung

This figure shows the co-authorship network connecting the top 25 collaborators of May Tun Saung. A scholar is included among the top collaborators of May Tun Saung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with May Tun Saung. May Tun Saung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Ke, Xiyu, et al.. (2025). A nanoparticle platform for the co-delivery of multiple antigen epitope peptides and STING agonist to lymph nodes for cancer immunotherapy. International Journal of Pharmaceutics. 680. 125757–125757. 1 indexed citations
2.
Saung, May Tun, Lorraine Pelosof, Sandra J. Casak, et al.. (2021). FDA Approval Summary: Nivolumab Plus Ipilimumab for the Treatment of Patients with Hepatocellular Carcinoma Previously Treated with Sorafenib. The Oncologist. 26(9). 797–806. 77 indexed citations
3.
4.
Fujiwara, Kenji, May Tun Saung, Hao Jing, et al.. (2020). Interrogating the immune-modulating roles of radiation therapy for a rational combination with immune-checkpoint inhibitors in treating pancreatic cancer. Journal for ImmunoTherapy of Cancer. 8(2). e000351–e000351. 29 indexed citations
5.
6.
Blair, Alex B., Victoria M. Kim, Stephen Muth, et al.. (2019). Dissecting the Stromal Signaling and Regulation of Myeloid Cells and Memory Effector T Cells in Pancreatic Cancer. Clinical Cancer Research. 25(17). 5351–5363. 64 indexed citations
7.
8.
Osipov, Arsen, May Tun Saung, Lei Zheng, & Adrian Murphy. (2019). Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape. Journal for ImmunoTherapy of Cancer. 7(1). 224–224. 174 indexed citations
9.
Ke, Xiyu, Gregory P. Howard, Haoyu Tang, et al.. (2019). Physical and chemical profiles of nanoparticles for lymphatic targeting. Advanced Drug Delivery Reviews. 151-152. 72–93. 111 indexed citations
10.
Saung, May Tun, Xiyu Ke, Gregory P. Howard, Lei Zheng, & Hai‐Quan Mao. (2019). Particulate carrier systems as adjuvants for cancer vaccines. Biomaterials Science. 7(12). 4873–4887. 21 indexed citations
11.
Saung, May Tun, Stephen Muth, Ding Ding, et al.. (2018). Targeting myeloid-inflamed tumor with anti-CSF-1R antibody expands CD137+ effector T-cells in the murine model of pancreatic cancer. Journal for ImmunoTherapy of Cancer. 6(1). 118–118. 47 indexed citations
12.
Saung, May Tun & Lei Zheng. (2017). Current Standards of Chemotherapy for Pancreatic Cancer. Clinical Therapeutics. 39(11). 2125–2134. 83 indexed citations
13.
Saung, May Tun, Armon Sharei, Viktor A. Adalsteinsson, et al.. (2016). A Size‐Selective Intracellular Delivery Platform. Small. 12(42). 5873–5881. 31 indexed citations
14.
Kim, YongTae, Mark E. Lobatto, Tomohiro Kawahara, et al.. (2014). Probing nanoparticle translocation across the permeable endothelium in experimental atherosclerosis. Proceedings of the National Academy of Sciences. 111(3). 1078–1083. 154 indexed citations
15.
Saung, May Tun, Valentı́n Fuster, Ewald Roessl, et al.. (2012). Effect of Computed Tomography Scanning Parameters on Gold Nanoparticle and Iodine Contrast. Investigative Radiology. 47(8). 475–481. 83 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James W. Opzoomer Breakdown of academic impact, for papers by Myrofora Panagi Breakdown of academic impact, for papers by Crismita Dmello Breakdown of academic impact, for papers by Xiaoli Wei Breakdown of academic impact, for papers by Ashvin R. Jaiswal Breakdown of academic impact, for papers by Matthew Lin Breakdown of academic impact, for papers by Yuan‐Tong Liu Breakdown of academic impact, for papers by Chayanon Ngambenjawong Breakdown of academic impact, for papers by Christina Hartl Breakdown of academic impact, for papers by Lenka Kašíková
Rankless by CCL
2026